Nystatin Oral Suspensions/Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets/Suspensions
Available Strengths: Tab: 500,000 units, 1,000,000 units; Sus: 100,000 units/mL, 500,000 units/5 mL
Reference Brands: Mycostatin, Nilstat, Nystop(US)
Category:
Anti-fungal
Nystatin tablets and suspension inhibit fungal cell membrane synthesis by binding to ergosterol, disrupting membrane integrity and causing cell death. They effectively treat superficial oral and gastrointestinal candidiasis, offering rapid relief, minimal systemic absorption, and broad antifungal activity. Benefits include targeted therapy and high safety for mucosal fungal infections.
Nystatin Oral Suspensions/Tablets is available in Tablets/Suspensions
and strengths such as Tab: 500,000 units, 1,000,000 units; Sus: 100,000 units/mL, 500,000 units/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nystatin Oral Suspensions/Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nystatin Oral Suspensions/Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nystatin tablets and suspension are approved in the EU and US for treating superficial candidiasis. In the EU, formulations like Nystan are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on comprehensive clinical data; generic versions are available. Both regions require detailed dossiers for approval and ongoing pharmacovigilance to ensure safety and efficacy. For expert assistance with regulatory dossiers, registration, and compliance, visit PharmaTradz. We streamline market access for nystatin tablets and suspension, ensuring adherence to European and American standards for safe, effective antifungal therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing